Related references
Note: Only part of the references are listed.Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions
Palle Bager et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Efficacy and Safety of Ferric Carboxymaltose and Other Formulations in Iron-Deficient Patients: A Systematic Review and Network Meta-analysis of Randomised Controlled Trials
Carla Rognoni et al.
CLINICAL DRUG INVESTIGATION (2016)
Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose
Susann Neiser et al.
BIOMETALS (2015)
Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management
J. Szebeni et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
The Safety of Intravenous Iron Preparations: Systematic Review and Meta-analysis
Tomer Avni et al.
MAYO CLINIC PROCEEDINGS (2015)
Iron-Deficiency Anemia
Clara Camaschella
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management
David Rampton et al.
HAEMATOLOGICA (2014)
Hypersensitivity from Intravenous Iron Products
Andreas J. Bircher et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2014)
Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety
Michael Auerbach et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2010)
Clinical update: intravenous iron for anaemia
Michael Auerbach et al.
LANCET (2007)
Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity
J Szebeni
TOXICOLOGY (2005)
Share Paper
